Form 4: Bio-Techne Corp Executive William Geist Reports Stock Transactions
SEC Form 4
William Geist, President of Protein Sciences at Bio-Techne Corp, reports the vesting of restricted stock units and the disposition of shares to cover tax obligations.
Summary
- On February 1, 2025, William Geist, President of Protein Sciences at Bio-Techne Corp, engaged in transactions involving the company's stock.
- 3,320 restricted stock units vested, converting into common stock.
- 1,109 shares were disposed of at a price of $73.55 to satisfy tax obligations related to the vesting of the restricted stock units.
- Following these transactions, Geist directly owns 13,292 shares of Bio-Techne common stock.
- Geist also holds various derivative securities, including stock options and performance-based restricted stock units, with different vesting schedules and exercise prices.
Sentiment
Score: 5
Explanation: The document is a standard regulatory filing detailing stock transactions by an executive. It doesn't inherently convey positive or negative sentiment about the company's prospects.
Future Outlook
The document does not contain any specific forward-looking statements regarding the company's future performance.
Industry Context
This Form 4 filing is a routine disclosure related to insider transactions. It provides transparency into the trading activities of company executives, which is a standard practice in publicly traded companies. Monitoring these filings can provide insights into management's perspective on the company's stock.
Comparison to Industry Standards
- Form 4 filings are standard practice for publicly traded companies and their executives.
- The vesting schedules and option grants are typical components of executive compensation packages in the biotech industry.
- Similar filings can be observed for executives at companies like Thermo Fisher Scientific (TMO) and Danaher Corporation (DHR).
Stakeholder Impact
- The transactions may have a minor impact on shareholders due to the change in ownership, but the overall effect is likely minimal.
Key Dates
| Date | Description |
|---|---|
| 02/01/2025 | Date of transaction: Vesting of restricted stock units and disposition of shares. |
| 02/04/2025 | Date of signature of the report. |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.